At Omico, I support business development by democratizing access to our unique genomic datasets, providing critical clinical insights through analytics for pharmaceutical clients. My role involves helping clients understand the treatment landscape, enhancing clinical trials, and supporting government submissions especially for drugs that target specific mutations. In addition to business development, I develop and manage ETL processes to collect and process our complex health data. I manage and deliver comprehensive analyses through RWE projects as well as maintaining our RWE PowerBi visualization platforms.

Doing even more what I love, which is to engage with our clients in delivering comprehensive healthcare expertise, and specialized insights to clients through provision, sales, and project management.Provide stasticals insights, projects as well as Machine Learning solution specialized for healthcare databases using foundations models.

Doing what I love, which is thinking creatively to generate new solutions and make improvements to current processes that deliver value to our customers. This involves Investigating challenges, analysing complex business problems and making recommendations to improve on data quality and procedures whilst applying best practices.

I am an expert in end-to-end data analytics, utilizing longitudinal patient health datasets from global healthcare databases. With my client management skills, I provide innovative healthcare strategies and real-world solutions to diverse providers.Notable accomplishments include complex data analytics on international patient health datasets, leading to publications, product development, therapy area expertise, and market insights using real-world evidence. Proficient in Matlab, SQL, and Python coding.

Research, and development of software tools for patients with lung cancer to be treated with novel radiation therapy technology • Backend development of Matlab and C# code for quality assurance• Expertise and advice to oncologist about implementation of novel radiation therapy techniques• Analysis of clinical data to determine the treatment benefits– local control, overall survival, probability of tumour recurrence